Gujarat Inject Kerala Financial Ratios
GUJINJEC · Healthcare · Current price ₹12.63
P/E ratio
60.1x
P/B ratio
15.7x
ROE
—
ROCE
12.5%
Debt / Equity
0.00
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 60.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 15.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | — | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 12.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Gujarat Inject Kerala's latest numbers.
Gujarat Inject Kerala profitability
Profitability ratios for Gujarat Inject Kerala are incomplete in our data.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 60.1x, Gujarat Inject Kerala is conservatively financed. Our overall business-quality score for the company is 3.0 / 10.
Understand the ratios
More on Gujarat Inject Kerala
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.